Germany: International Conference PLM in pharmaceutical & biotechnical development

The complexity of today´s pharmaceutical market requires more efficient drug development and production. Companies must shift more attention to manufacturing operations. Manufacturing is at the center of the pharma product lifecycle and it accounts for 25% of pharmaceutical companies cost.

As a result, regulators are calling for scientific and risk-based approaches such as quality by design (QbD) and process analytical technology (PAT) that integrate design and manufacturing.

Conference Website